Thomas Hermanns

29.1k total citations · 1 hit paper
185 papers, 4.6k citations indexed

About

Thomas Hermanns is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Thomas Hermanns has authored 185 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Pulmonary and Respiratory Medicine, 73 papers in Surgery and 56 papers in Molecular Biology. Recurrent topics in Thomas Hermanns's work include Prostate Cancer Diagnosis and Treatment (41 papers), Prostate Cancer Treatment and Research (34 papers) and Bladder and Urothelial Cancer Treatments (32 papers). Thomas Hermanns is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (41 papers), Prostate Cancer Treatment and Research (34 papers) and Bladder and Urothelial Cancer Treatments (32 papers). Thomas Hermanns collaborates with scholars based in Switzerland, Germany and Canada. Thomas Hermanns's co-authors include Tullio Sulser, Peter J. Wild, Christian D. Fankhauser, Cédric Poyet, Arnoud J. Templeton, Holger Moch, Daniel Eberli, Niels J. Rupp, Eitan Amir and Glen Kristiansen and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Thomas Hermanns

168 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

2014 546 citations Arnoud J. Templeton, Olga Ace et al. Cancer Epidemiology Biomarkers & Prevention profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Hermanns Switzerland	35	1.9k	1.5k	1.3k	1.2k	716	185	4.6k
Brian D. Robinson United States	39	2.4k 1.2×	1.2k 0.8×	1.6k 1.2×	1.2k 1.0×	1.0k 1.4×	146	5.1k
Marc‐Oliver Grimm Germany	35	2.5k 1.3×	2.5k 1.7×	1.6k 1.3×	2.4k 2.0×	759 1.1×	243	5.8k
Nam Hoon Cho South Korea	38	1.2k 0.7×	1.3k 0.9×	1.8k 1.4×	1.0k 0.8×	991 1.4×	223	4.9k
Toyonori Tsuzuki Japan	40	2.6k 1.4×	1.4k 0.9×	1.1k 0.9×	1.6k 1.3×	507 0.7×	288	5.9k
Lakshmi P. Kunju United States	38	2.8k 1.5×	978 0.7×	1.9k 1.4×	1.1k 0.9×	1.1k 1.6×	130	4.8k
Niels Willi Switzerland	24	1.7k 0.9×	1.7k 1.1×	1.5k 1.2×	629 0.5×	623 0.9×	45	4.7k
Thomas A. Gardner United States	33	1.3k 0.7×	802 0.5×	1.4k 1.0×	825 0.7×	338 0.5×	159	3.7k
Warick Delprado Australia	38	2.3k 1.2×	965 0.6×	754 0.6×	584 0.5×	477 0.7×	101	4.2k
Kyung Chul Moon South Korea	32	1.5k 0.8×	630 0.4×	1.2k 1.0×	848 0.7×	351 0.5×	228	3.9k
Mercè Jordà United States	33	1.3k 0.7×	1.0k 0.7×	855 0.7×	977 0.8×	461 0.6×	157	3.2k

Countries citing papers authored by Thomas Hermanns

Since Specialization

Citations

This map shows the geographic impact of Thomas Hermanns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hermanns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hermanns more than expected).

Fields of papers citing papers by Thomas Hermanns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Hermanns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hermanns. The network helps show where Thomas Hermanns may publish in the future.

Co-authorship network of co-authors of Thomas Hermanns

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Hermanns. A scholar is included among the top collaborators of Thomas Hermanns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Hermanns. Thomas Hermanns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hermanns, Thomas, et al.. (2025). A family of bacterial Josephin-like deubiquitinases with an irreversible cleavage mode. Molecular Cell. 85(6). 1202–1215.e5. 3 indexed citations

Fankhauser, Christian D., Marian S. Wettstein, Ailsa J. Christiansen, et al.. (2024). Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levels. Urologic Oncology Seminars and Original Investigations. 42(12). 455.e9–455.e13.

Hermanns, Thomas, et al.. (2023). Functional and structural diversity in deubiquitinases of the Chlamydia-like bacterium Simkania negevensis. Nature Communications. 14(1). 7335–7335. 4 indexed citations

Laudicella, Riccardo, Jan H. Rüschoff, Daniela A. Ferraro, et al.. (2022). Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI. European Journal of Nuclear Medicine and Molecular Imaging. 49(11). 3917–3928. 23 indexed citations

Rakauskas, Arnas, Valérie Cesson, Karim Saba, et al.. (2022). Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer. Cancers. 14(5). 1135–1135. 8 indexed citations

Kranzbühler, Benedikt, Burkhardt Seifert, Birgit Helmchen, et al.. (2022). Is Regular Radiographic Upper Urinary Tract Imaging for Surveillance of Non-Muscle Invasive Bladder Cancer Justified?. Cancers. 14(22). 5586–5586.

Beyer, J., Dominik Berthold, Richard Cathomas, et al.. (2021). Swiss germ-cell cancer consensus recommendations. Swiss Medical Weekly. 151(3334). w30023–w30023. 1 indexed citations

Saba, Karim, Tullio Sulser, Daniel Eberli, et al.. (2021). Prostate cancer detection rate in men undergoing transperineal template‐guided saturation and targeted prostate biopsy. The Prostate. 82(3). 388–396. 18 indexed citations

Lorch, Anja, J. Beyer, Daniel Eberli, et al.. (2020). Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: Analysis of published case series data. European Urology Open Science. 21. S243–S243. 2 indexed citations

10.

Erichsen, Lars, Hans‐Helge Seifert, Wolfgang A. Schulz, et al.. (2020). Basic Hallmarks of Urothelial Cancer Unleashed in Primary Uroepithelium by Interference with the Epigenetic Master Regulator ODC1. Scientific Reports. 10(1). 3808–3808. 10 indexed citations

11.

Wettstein, Marian S., Kathy Li, Christian D. Fankhauser, et al.. (2020). Association between surgical case volume and survival in T1 bladder cancer: A plea for regionalization of care?. Canadian Urological Association Journal. 14(9). 1 indexed citations

12.

Erichsen, Lars, Foued Ghanjati, Cédric Poyet, et al.. (2018). Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis. Scientific Reports. 8(1). 3477–3477. 11 indexed citations

13.

Nießen, Markus, et al.. (2017). Boundary layer approximation for melt film dynamics in laser fusion cutting. Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft). 1 indexed citations

14.

Zhong, Qing, Tiannan Guo, Markus Rechsteiner, et al.. (2017). A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients. Scientific Data. 4(1). 170014–170014. 18 indexed citations

15.

Nowicka, Anna, Arndt Hartmann, Thomas Hermanns, et al.. (2015). pVHL/HIF-Regulated CD70 Expression Is Associated with Infiltration of CD27+ Lymphocytes and Increased Serum Levels of Soluble CD27 in Clear Cell Renal Cell Carcinoma. Clinical Cancer Research. 21(4). 889–898. 56 indexed citations

16.

Templeton, Arnoud J., Olga Ace, Mairéad G. McNamara, et al.. (2014). Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. Cancer Epidemiology Biomarkers & Prevention. 23(7). 1204–1212. 546 indexed citations breakdown →

17.

Hermanns, Thomas, Claudia Matter, Lotta von Boehmer, et al.. (2013). Spontaneous Peripheral T-cell Responses toward the Tumor-Associated Antigen Cyclin D1 in Patients with Clear Cell Renal Cell Carcinoma. Cancer Immunology Research. 1(5). 288–295. 7 indexed citations

18.

Mortezavi, Ashkan, Thomas Hermanns, Hans‐Helge Seifert, et al.. (2011). KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy. Clinical Cancer Research. 17(5). 1111–1121. 84 indexed citations

19.

Gerhardt, Josefine, Silvia Behnke, Florian Fritzsche, et al.. (2011). The Androgen-Regulated Calcium-Activated Nucleotidase 1 (CANT1) Is Commonly Overexpressed in Prostate Cancer and Is Tumor-Biologically Relevant in Vitro. American Journal Of Pathology. 178(4). 1847–1860. 29 indexed citations

20.

Sørensen, Karina D., Peter J. Wild, Ashkan Mortezavi, et al.. (2009). Genetic and Epigenetic SLC18A2 Silencing in Prostate Cancer Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy. Clinical Cancer Research. 15(4). 1400–1410. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact